4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-055203
10% owner sold 48,640 shares at an average $29.20 ($1,420,394)
From the SEC's structured data for this filing
Trades in this filing
UBS Oncology Impact Fund L.P. · 10% owner
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-03 | Sale : show line 1 in the form | −12,731 | $29.60 | $376,838 | 7,724,085 | D |
| 2021-09-07 | Sale : show line 2 in the form | −25,067 | $29.04 | $727,946 | 7,699,018 | D |
| 2021-09-08 | Sale : show line 3 in the form | −10,842 | $29.11 | $315,611 | 7,688,176 | D |
| Open-market sales · 48,640 sh · avg $29.20 · $1,420,394 | ||||||
Loading xslF345X03/doc4.xml…